Waycross Partners, LLC Gilead Sciences, Inc. Transaction History

Waycross Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $908,319 - $1.03 Million	-14,000 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$63.47 - $69.35 $853,481 - $932,549	13,447 Added 2431.65%	14,000 $964,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $853,481 - $932,549	-13,447 Reduced 96.05%	553 $23,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $840,000 - $958,439	14,000 New	14,000 $905,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Waycross Partners, LLC with notifications on news.